CLClinicLens

Unclassified

FDA Approves Hypertriglyceridemia Drug That May Reduce Pancreatitis Risk | ClinicLens

The US Food and Drug Administration (FDA) approved a new treatment for adults with severe hypertriglyceridemia, the first shown to reduce the risk of acute pancreatitis.

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.